Novanta Inc. (NOVT)
NASDAQ: NOVT · Real-Time Price · USD
138.91
+1.14 (0.83%)
Jul 30, 2026, 4:00 PM EDT - Market closed
Novanta Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,005 | 980.6 | 949.25 | 881.66 | 860.9 | 706.79 |
Revenue Growth | 5.59% | 3.30% | 7.66% | 2.41% | 21.80% | 19.67% |
Gross Profit Gross Profit Growth | 444.51 | 435.28 | 421.55 | 399.9 | 378.47 | 300.33 |
Operating Income Operating Income Growth | 89.13 | 94.01 | 110.58 | 110.5 | 103.08 | 64.05 |
Net Income Net Income Growth | 53.72 | 53.83 | 64.09 | 72.88 | 74.05 | 50.33 |
Earnings Per Share EPS Growth | 1.38 | 1.47 | 1.77 | 2.02 | 2.06 | 1.41 |
EPS Growth | -29.59% | -16.95% | -12.38% | -1.94% | 46.10% | 12.80% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Automation Enabling Technologies Automation Enabling Technologies Growth | 508.91 | 500.84 | 490.62 | 499.22 | 534.09 |
Medical Solutions Medical Solutions Growth | 496.03 | 479.77 | 458.63 | 382.44 | 326.81 |
Revenue (Total) Revenue (Total) Growth | 1,005 | 980.6 | 949.25 | 881.66 | 860.9 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 388.8 | 380.87 | 113.99 | 105.05 | 100.11 | 117.39 |
Total Debt Total Debt Growth | 288.36 | 299.56 | 467.07 | 399.91 | 484.06 | 487.49 |
Net Cash (Debt) Net Cash Growth | 100.44 | 81.31 | -353.08 | -294.86 | -383.96 | -370.1 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 2.64 | 2.22 | -9.77 | -8.18 | -10.69 | -10.34 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 83.98 | 64.06 | 158.51 | 120.08 | 90.78 | 94.63 |
Capital Expenditures CapEx Growth | -15.48 | -15.63 | -17.16 | -19.96 | -19.64 | -19.98 |
Free Cash Flow Free Cash Flow Growth | 68.5 | 48.43 | 141.35 | 100.11 | 71.14 | 74.65 |
Free Cash Flow Growth | -51.88% | -65.74% | 41.19% | 40.74% | -4.71% | -42.45% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 44.23% | 44.39% | 44.41% | 45.36% | 43.96% | 42.49% |
Operating Margin | 8.87% | 9.59% | 11.65% | 12.53% | 11.97% | 9.06% |
Pretax Margin | 6.92% | 7.10% | 8.33% | 9.50% | 10.12% | 7.95% |
Profit Margin | 5.35% | 5.49% | 6.75% | 8.27% | 8.60% | 7.12% |
FCF Margin | 6.82% | 4.94% | 14.89% | 11.36% | 8.26% | 10.56% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 98.33 | 80.95 | 86.31 | 83.37 | 65.96 | 125.06 |
Forward PE | 36.91 | 32.87 | 44.41 | 58.24 | 42.36 | 60.23 |
P/FCF Ratio | 76.57 | 87.64 | 38.84 | 60.25 | 68.21 | 84.09 |
PS Ratio | 5.22 | 4.33 | 5.78 | 6.84 | 5.64 | 8.88 |